Clinical Study of Apatinib and XELOX Combination Regimen to Treat Colorectal Cancer Patients
Ontology highlight
ABSTRACT: This study makes an observation over the objective response rate of Apatinib and XELOX combination regimen in the first-line treatment of metastatic colorectal cancer. All the participants will receive the treatment of Apatinib and XELOX combination regimen.
DISEASE(S): Colorectal Neoplasms
PROVIDER: 2219525 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA